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Introduction
Spinal anesthesia is considered as one of the neuraxial 
blocks which results in (while injecting drug in 
centroneuraxis) sympathetic block, sensory, and motor 
block (1,2). Spinal anesthesia is one of the common 
methods used in surgeries; but, due to time limitations 
and since anesthetic duration of these drugs is not enough 
for a surgery to be completed, additive drugs are normally 
used to increase the duration of surgeries. Vasoconstrictors 
are one of these additive drugs and the most applicable 
ones are epinephrine 0.1 and 0.2 mg and phenylephrine 
2 mg (3).
These drugs reduce spinal blood flow and subsequently 
reduce the removal of local anesthetic solution and cause 
anti-nociception effect by stimulating alpha-adrenergic 
receivers (1,3). Most of the researchers believe that 
adding vasoconstrictors to local anesthetic solution can 
be dangerous especially regarding phenylephrine and 
epinephrine which are considered strong vasoconstrictors 
and can cause reduction of spinal blood reception (1). In 
some studies, increased transient neurologic symptoms 
have been reported after adding phenylephrine and 
epinephrine to tetracaine (3). In addition, adding 
epinephrine in spinal anesthesia can increase lidocaine 
nervous damages. Also, adding this drug to local 
anesthetic solution in diabetic patients can increase the 
risk of ischemic nervous damages (1).
Other drugs added to local anesthetic solutions break 
acetylcholine, release nitric oxide in spinal cord and thus 
increase block duration and intensity. Neostigmine is one 
of the drugs whose application has been questioned due 
to nausea and lengthened motor block in combination 
with local anesthetic drugs (1). Adding opioids to local 
anesthetic drugs increases their effects and decreases pain 
after operation. However, using these drugs is not common 
since they delay patient’s release from hospital and cause 
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Abstract
Objective: In order to prolong the duration of intrathecal lidocaine, various drugs are 
used along with it. Due to the promising effects of tizanidine on central nervous system, 
it can be assumed that tizanidine can have a positive effect on increasing the anesthesia 
duration too. Thus, we aimed to investigate the effect of oral tizanidine on the duration of 
lidocaine spinal anesthesia.
Methods: This double blind clinical trial was conducted on 40 male patients waiting for 
elective leg surgery with the age range of 20-60 years in one of the educational hospitals 
of Kerman University of Medical Sciences, Iran. We used simple random sampling and our 
participants were assigned into 2 groups (placebo and oral tizanidine receivers). Spinal 
anesthesia with 1 mg/kg of hyperbaric lidocaine 5% was performed in both groups. In 
tizanidine group, patients received 4 mg of oral tizanidine one hour before spinal anesthesia. 
Sensory block was examined by pin prick test and all anesthetic duration including start 
block until reduction of sensory level was calculated at 2 lower dermatomes.
Results: Findings showed that oral tizanidine compared to placebo can cause a 10-15 
minute increase in patients’ lidocaine spinal anesthesia. Therefore, the average anesthesia 
time for tizanidine group increased meaningfully (P = 0.03). In addition, tizanidine can 
sedate patients during surgery (P = 0.00) or in recovery (P = 0.003).
Conclusion: Based on the results, tizanidine increased the duration of lidocaine so oral 
tizanidine can be used to prolong the duration of lidocaine spinal anesthesia.
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the patients to be hospitalized regarding respiratory 
suppression (3). Adding clonidine to local anesthetic 
drugs is not as effective as narcotics and at the same time 
increases hypotension and sympatholytic effects of local 
anesthetic drugs and lengthens motor blocks (3,4)
Like clonidine, tizanidine is an alpha-2-adernorceptor 
agonist which is mainly used as a relaxant with central 
effect. Derivatives of clonidine can cause some effects 
like relaxation, anxiety, and pain reduction; whereas 
they reduce blood pressure and create less bradycardia. 
Tizanidine has a direct effect on spinal cord and prevents 
“simulating amino acids” (NMDA receptors stimulant) 
from releasing and its preemptive effects have in fact been 
known (5).
Tizanidine side-effects are mainly related to its dose 
and include sleepiness, xerostomia, fatigue, weakness, 
head-ache, bradycardia, arterial blood pressure drop, 
and digestive and hepatic disorders (6). This drug is 
available in Iran markets in the form of 2 and 4 mg pills. 
It is absorbed by digestive system and reaches maximum 
plasma con-centration within 1-2 hours; and its excreting 
half-life is 2-4 hours (7).
Nowadays, performing spinal anesthesia in surgeries 
limited to lower limbs and pelvis has been taken into huge 
consideration regarding less side effects, easy performance, 
patient’s satisfaction, and immediate anesthesia. Therefore, 
to lengthen anesthesia duration and to improve its quality, 
various drugs have been used. Concerning the benefits and 
advantages of tizanidine rather than clonidine especially 
in terms of homodynamic (8) and cardiovascular stability; 
and regarding the recommendations found in previous 
studies considering the application of oral tizanidine pills 
to lengthen neuraxial anesthesia; and due to its relaxation 
and anti-nociception effects, we decided to examine the 
effect of 4-miligram Tizanidine pill (taken one hour prior 
to surgery) on duration of lidocaine spinal anesthesia in a 
clinical trial.
Methods
This study was a randomized double-blind, clinical trial. 
Sampling was simple and 40 male patients waiting for 
elective leg surgery with the age range of 20-60 entered 
the study (Class American Society of Anesthetists [ASA] 
I & II were selected in one of the educational hospitals of 
Kerman). These patients were not prohibited from taking 
tizanidine and performing spinal anesthesia. At first, they 
were visited and consulted before entering into the surgery 
room and those who did not sign the consent form were 
omitted from the study. After determining the necessary 
criteria, patients were placed in one of the two study 
groups. Patients with cardiovascular, hepatic, and renal 
diseases, those who used narcotics and alcohol and those 
who used anti-hypertension and beta-blocker drugs were 
excluded. One hour prior to the surgery, patients took 
oral tizanidine or placebo (in packages similar to original 
drug) with 30-50 mL water. After arriving to the surgery 
room, patients were placed on surgery beds, and then 
their electrocardiography, pulse oximeter, non-aggressive 
blood pressure, and sedation levels were monitored and 
evaluated. All of the patients received 7 cc/kg crystalloid 
ringer liquid as inter-vascular compensatory volume. 
Then in a sitting position, spinal anesthesia was done 
with 1 mg/kg hyperbaric lidocaine 5% using Quincke 
23 G Needle in third and fourth or fourth and fifth 
lumbar apace; all sterilization conditions were observed. 
Immediately after injection, patients were asked to lie in a 
supine position and again their electrocardiography, pulse 
oximeter, blood pressure, heartbeat, and sedation (based 




1= sleepy or sedate who awakes easily
2= sleepy who reacts quickly to verbal stimulus
3= sleepy who reacts to verbal stimulus with a short delay 
4= unconscious
Anesthesia duration was measured (in terms of minute) 
from anesthesia stability time in the highest sensory 
dermatome to anesthesia return to two lower dermatomes 
and block recovery based on reduction of anesthesia 
surface to four lower dermatomes. Anesthetic surface was 
examined using pin prick after inter-spinal injection.
If the patient’s systolic blood pressure was less than 90 
mm/silver, ephrin drug was used to correct it and in case 
of nausea, vomit, or heartbeat rate less than 50 pulse/min, 
0.6 mg venous atropine was prescribed. After collecting 
the information, data were recorded in SPSS version 12. 
To compare data, t test and Mann–Whitney U test were 
used. Concerning qualitative variables, chi-square test was 
used accordingly. Meaningful level was considered to be 
0.05.
Results
Demographic indexes like age, weight as well as basic 
blood pressure and heartbeat in both groups revealed no 
significant differences between these two groups (Table 
1). Results showed that oral tizanidine, compared to 
placebo, can cause a 10-15 minute increase in patients’ 
lidocaine spinal anesthesia so that the average anesthesia 
time for tizanidine and placebo groups was 57±16 and 
47±11 minutes respectively (increased meaningfully, P = 
0.03). However, the stability time of spinal anesthesia 
in tizanidine and placebo was 8±2.9 and 7±2.5 minutes 
respectively (no statistically significant difference) 
(Table 2).
Tizanidine did not cause significant hemodynamic 
interference unlike placebo group. Blood pressure and 
heart rate changes in both groups were not related to a 
special time and no meaningful relationship was found 
in both groups regarding time of mentioned changes 
(whether before, during or after operation) (Figures 1 
and 2).
Taheri et al
Journal of Emergency Practice and Trauma, 2018, 4(2), 62-6664
Another finding of this research is that, tizanidine can 
sedate patients during surgery (P = 0.00) or in recovery 
(P = 0.003); it also decreases the need for using sedation 
and venous sedatives. These results were statistically very 
valuable and meaningful (Table 3).
No increase was reported in the use of venous liquids, 
atropine and ephedrine in those who had used tizanidine. 
None of the patients in this study showed a special problem 
during anesthesia or after it.
We also evaluated the side effects of drug (e.g. bradycardia, 
nausea, reduced blood pressure, headache, and sleepiness) 
in both groups. We did not observe a significant difference 
between groups.
Discussion
Results of this research showed that the consumption of 
oral tizanidine one hour prior to surgery can lengthen 
lidocaine spinal anesthesia. Having tranquilizing and 
sedative effects, this drug reduced patients’ fear and 
anxiety during operation and increased their relaxation 
during surgery and recovery and thus decreased the 
consumption of venous tranquilizers. Moreover, using 
tizanidine in lidocaine spinal anesthesia did not cause 
any changes in needs to atropine, ephedrine, and venous 
liquids.
Spinal anesthesia is one of the common methods used 
in surgeries; however, due to time limitations and since 
anesthetic duration of these drugs is not enough for a 
surgery to be completed, additive drugs are normally used 
along with them to increase the duration of surgeries. 
However, using these drugs in inter-spinal injections may 
cause cardiovascular problems (1,2).
In a study carried out in 1995 in Japan on gynecologic 
patients who had tetracaine spinal anesthesia, the effects 
of oral tizanidine and clonidine were compared. The 
results showed that both drugs could lengthen tetracaine 
spinal anesthesia while tizanidine had lower side effects 
and caused better hemodynamic stability (8). In this 
study, tizanidine increased lidocaine’s effect and did not 
cause homodynamic effects.
In another research which was done in 2008, inter-
Table 1. Comparison of general indexes in both groups
Examined index
Treatment group (mean ±SD)
P value
Placebo Tizanidine
Weight (kg) 68.1±7 67.7±5 0.8
Age (y) 33.1±12 31.1±10 0.6
Basic blood pressure (mm Hg) 125.81±13 127.79±10 1
Average basic blood pressure (mm Hg ) 95.24±11 94.97±12 0.09
Average blood pressure during surgery (mm Hg ) 84.7±19 89.3±17 0.08
Average basic heartbeat (beat/min) 88.9±18 85.85±12 0.05
Table 2. Comparison of spinal anesthesia in various treatment groups (min)
Examined index
Treatment group (mean ± SD)
P value
Placebo Tizanidine
Beginning point 7.2±2.5 8.0±2.9 0.35
Reduction of sensory block to 2 dermatomes 46.5±11.0 56.6±16.0 0.03
Reduction of sensory block to 4 dermatomes 72.4±14.0 60.7±13.0 0.01
Recovery duration 26.5±11.0 19.6±9.0 0.05
Figure 1. The trend of heartbeat changes (number/minute) in both 
groups
Figure 2. The trend of average blood pressure changes (mm Hg) in 
both groups.
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spinal lidocaine was added to local anesthetic drugs. 
The findings showed an increase in arterial hypotension 
episodes but no bradycardia was observed (4). In this 
research, bradycardia and arterial hypotension were not 
found in patients.
Asgari et al investigated the effect of subdiaphragmatic 
infiltration of lidocaine 1% at the beginning of surgery 
combined with spinal anesthesia in order to reduce pain, 
but contrary to prior studies, their results showed that 
mean severity of pain among patients was not significant 
and adding lidocaine 1% did not affect severity of pain. In 
the present study, spinal anesthesia was done by 1 mg/kg 
of hyperbaric lidocaine 5% (9).
In a study carried out by Gabriel and Gordin in 2001 in the 
United States, clonidine along with local anesthetic drugs 
increased sensory block regardless of starting point (5). In 
our study, starting point was not influenced by tizanidine, 
and anesthesia duration increased.
In another research performed by Miettinen et al, sedative 
effects of 12 mg oral tizanidine was comparable with 50 μg 
clonidine but clonidine effects were longer; but, diastolic 
blood pressure drop in clonidine was higher than that of 
tizanidine. In this research, oral tizanidine was introduced 
as a suitable substitute for clonidine during operation (7).
Rupani et al indicated that preoperative oral tizanidine 
improved the severity of postoperative analgesia without 
increasing side effect. Their results are along with the 
present stud (10).
A study conducted by Shoeibi et al showed that prescription 
of oral tizanidine as premedication patients with spinal 
anesthesia in order to reduction the pain arises from 
needle puncture was significant and increases satisfaction 
of anesthesia due to prepared analgesia. Furthermore, the 
mean of heart rate and diastolic blood pressure in patients 
treated with tizanidine was lower than placebo group (11).
Talakoub et al remarked that administration of 
tizanidine before operation in patients scheduled for 
elective laparoscopic cholecystectomy under general 
anesthesia improves postoperative analgesia, provides 
less pain intensity and decreases the amount of analgesic 
consumption (12).
Henney et al carried out their study about pediatric safety 
Table 3. Comparison of variables frequency (class ASA, sedation, 
atropine and ephedrine consumption)
Variable
Placebo (n=20) Drug (n=20) P 
valueNo. % No. %
Class ASA
I 18 90 18 90 1
II 2 10 2 10 1
Sedation before surgery 0 0 4 20 0.1
Sedation during surgery 1 5 15 75 0
Sedation in recovery 0 0 8 40 0.003
Ephedrine consumption 1 5 2 10 1
Atropine consumption 4 20 3 15 1
of tizanidine. They implied that the overall safety of 
tizanidine in the pediatric group was good. None of the 
patients in the present study had a special problem during 
anesthesia or after it and we did not observe significant 
differences between the two groups concerning the side 
effects of the drug (13).
In this research, the side effects of tizanidine such 
as hypotension, bradycardia, nausea, headache, and 
sleepiness in placebo and tizanidine groups were not 
significantly different, while patients’ relaxation was 
higher based on Kulka criterion.
Conclusion
In this study, the effect of oral tizanidine on the duration 
of lidocaine in spinal anesthesia was examined. It was 
shown that tizanidine increased the duration of lidocaine 
more than placebo; homodynamic change in both groups 
was not significant. It is suggested that various doses of 
tizanidine and various times of prescription prior to 
operation should be examined.
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